Literature DB >> 29414412

Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation.

Héctor Fernández-Susavila1, Cristina Mora2, Marta Aramburu-Núñez1, Rita Quintas-Rey3, Susana Arias1, Manuel Collado4, Esteban López-Arias1, Tomás Sobrino1, José Castillo1, Patrizia Dell'Era2, Francisco Campos5.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common form of hereditary stroke disorder. It is caused by mutations in NOTCH3 that lead to progressive degeneration of the smooth muscle cells in blood vessels. There is currently no treatment for this disorder. We reprogrammed to pluripotency blood mononuclear cells isolated from a patient carrying a NOTCH3 mutation by using a commercially available non-integrating system. The success in the generation of this iPSC line (IDISi001-A) suggests that the NOTCH3 mutation did not limit cell reprogramming and offers an unprecedented opportunity for studying and modeling CADASIL pathology.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29414412     DOI: 10.1016/j.scr.2018.01.023

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  3 in total

Review 1.  CADASIL from Bench to Bedside: Disease Models and Novel Therapeutic Approaches.

Authors:  Arianna Manini; Leonardo Pantoni
Journal:  Mol Neurobiol       Date:  2021-01-19       Impact factor: 5.590

2.  A Study of Congenital Protein C Deficiency With Infancy Onset of CADASIL in a Chinese Baby.

Authors:  Xiuli Yuan; Changgang Li; Xiaowen Chen; Liwei Liu; Guosheng Liu; Feiqiu Wen
Journal:  J Pediatr Hematol Oncol       Date:  2019-05       Impact factor: 1.289

3.  ER stress and Rho kinase activation underlie the vasculopathy of CADASIL.

Authors:  Karla B Neves; Adam P Harvey; Fiona Moreton; Augusto C Montezano; Francisco J Rios; Rhéure Alves-Lopes; Aurelie Nguyen Dinh Cat; Paul Rocchicciolli; Christian Delles; Anne Joutel; Keith Muir; Rhian M Touyz
Journal:  JCI Insight       Date:  2019-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.